896 related articles for article (PubMed ID: 28087528)
41. Immunogenicity and therapeutic effects of Ag85A/B chimeric DNA vaccine in mice infected with Mycobacterium tuberculosis.
Liang Y; Wu X; Zhang J; Xiao L; Yang Y; Bai X; Yu Q; Li Z; Bi L; Li N; Wu X
FEMS Immunol Med Microbiol; 2012 Dec; 66(3):419-26. PubMed ID: 23163873
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
[TBL] [Abstract][Full Text] [Related]
43. Live attenuated Salmonella vaccines displaying regulated delayed lysis and delayed antigen synthesis to confer protection against Mycobacterium tuberculosis.
Juárez-Rodríguez MD; Yang J; Kader R; Alamuri P; Curtiss R; Clark-Curtiss JE
Infect Immun; 2012 Feb; 80(2):815-31. PubMed ID: 22144485
[TBL] [Abstract][Full Text] [Related]
44. Design of a single-chain multi-enzyme fusion protein establishing the polyhydroxybutyrate biosynthesis pathway.
Mullaney JA; Rehm BH
J Biotechnol; 2010 May; 147(1):31-6. PubMed ID: 20214931
[TBL] [Abstract][Full Text] [Related]
45. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice.
Yuan W; Dong N; Zhang L; Liu J; Lin S; Xiang Z; Qiao H; Tong W; Qin C
Vaccine; 2012 Mar; 30(14):2490-7. PubMed ID: 21704108
[TBL] [Abstract][Full Text] [Related]
46. Induction of protective cellular immunity against Mycobacterium tuberculosis by recombinant attenuated self-destructing Listeria monocytogenes strains harboring eukaryotic expression plasmids for antigen 85 complex and MPB/MPT51.
Miki K; Nagata T; Tanaka T; Kim YH; Uchijima M; Ohara N; Nakamura S; Okada M; Koide Y
Infect Immun; 2004 Apr; 72(4):2014-21. PubMed ID: 15039321
[TBL] [Abstract][Full Text] [Related]
47. A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice.
Liu S; Gong Q; Wang C; Liu H; Wang Y; Guo S; Wang W; Liu J; Shao M; Chi L; Zhao K; Wang Z; Shi Y; Huang Y; Guli A; Zhang C; Kong X
Immunol Lett; 2008 May; 117(2):136-45. PubMed ID: 18339431
[TBL] [Abstract][Full Text] [Related]
48. Immunogenicity and therapeutic effects of recombinant Ag85AB fusion protein vaccines in mice infected with Mycobacterium tuberculosis.
Liang Y; Zhang J; Yang Y; Bai X; Yu Q; Li N; Hou Y; Shi Y; Wang L; Wu X
Vaccine; 2017 Jul; 35(32):3995-4001. PubMed ID: 28625522
[TBL] [Abstract][Full Text] [Related]
49. Sequential pulmonary immunization with heterologous recombinant influenza A virus tuberculosis vaccines protects against murine M. tuberculosis infection.
Muflihah H; Flórido M; Lin LCW; Xia Y; Triccas JA; Stambas J; Britton WJ
Vaccine; 2018 Apr; 36(18):2462-2470. PubMed ID: 29602704
[TBL] [Abstract][Full Text] [Related]
50. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
[TBL] [Abstract][Full Text] [Related]
51. Efficacy of parainfluenza virus 5 (PIV5)-based tuberculosis vaccines in mice.
Chen Z; Gupta T; Xu P; Phan S; Pickar A; Yau W; Karls RK; Quinn FD; Sakamoto K; He B
Vaccine; 2015 Dec; 33(51):7217-7224. PubMed ID: 26552000
[TBL] [Abstract][Full Text] [Related]
52. Biosynthesis of polyhydroxyalkanoates co-polymer in E. coli using genes from Pseudomonas and Bacillus.
Davis R; Anilkumar PK; Chandrashekar A; Shamala TR
Antonie Van Leeuwenhoek; 2008 Aug; 94(2):207-16. PubMed ID: 18357511
[TBL] [Abstract][Full Text] [Related]
53. DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope Mycobacterium tuberculosis vaccine.
Wu M; Li M; Yue Y; Xu W
Microbiol Immunol; 2016 Sep; 60(9):634-45. PubMed ID: 27531823
[TBL] [Abstract][Full Text] [Related]
54. Vesicular Stomatitis Virus-Vectored Multi-Antigen Tuberculosis Vaccine Limits Bacterial Proliferation in Mice following a Single Intranasal Dose.
Zhang M; Dong C; Xiong S
Front Cell Infect Microbiol; 2017; 7():34. PubMed ID: 28224119
[TBL] [Abstract][Full Text] [Related]
55. Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4-HspX.
Niu H; Hu L; Li Q; Da Z; Wang B; Tang K; Xin Q; Yu H; Zhang Y; Wang Y; Ma X; Zhu B
Vaccine; 2011 Nov; 29(51):9451-8. PubMed ID: 22024175
[TBL] [Abstract][Full Text] [Related]
56. Recombinant BCG approach for development of vaccines: cloning and expression of immunodominant antigens of M. tuberculosis.
Dhar N; Rao V; Tyagi AK
FEMS Microbiol Lett; 2000 Sep; 190(2):309-16. PubMed ID: 11034297
[TBL] [Abstract][Full Text] [Related]
57. Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis.
Mollenkopf HJ; Grode L; Mattow J; Stein M; Mann P; Knapp B; Ulmer J; Kaufmann SH
Infect Immun; 2004 Nov; 72(11):6471-9. PubMed ID: 15501778
[TBL] [Abstract][Full Text] [Related]
58. Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccine.
Zhang Y; Feng L; Li L; Wang D; Li C; Sun C; Li P; Zheng X; Liu Y; Yang W; Niu X; Zhong N; Chen L
Hum Vaccin Immunother; 2015; 11(7):1803-13. PubMed ID: 26076321
[TBL] [Abstract][Full Text] [Related]
59. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon.
Radosevic K; Wieland CW; Rodriguez A; Weverling GJ; Mintardjo R; Gillissen G; Vogels R; Skeiky YA; Hone DM; Sadoff JC; van der Poll T; Havenga M; Goudsmit J
Infect Immun; 2007 Aug; 75(8):4105-15. PubMed ID: 17526747
[TBL] [Abstract][Full Text] [Related]
60. The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis.
Andersen CS; Dietrich J; Agger EM; Lycke NY; Lövgren K; Andersen P
Infect Immun; 2007 Jan; 75(1):408-16. PubMed ID: 17074845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
